Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information

NACompletedINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Pulmonary EmbolismDeep Vein ThrombosisAtrial Fibrillation
Interventions
DRUG

Warfarin

2 mg tablets take as directed by study staff (based on INR)

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Newton-Wellesley Hospital

OTHER

collaborator

Spaulding Rehabilitation Hospital

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT00401414 - Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information | Biotech Hunter | Biotech Hunter